Managers / Q3 2025 · view latest →
LETKO, BROSSEAU & ASSOCIATES INC
CIK 0001297496 · 1800, MCGILL COLLEGE, SUITE 2510, MONTREAL, A8, H3A 3J6 · (514) 499-1200
Summary
Letko, Brosseau & Associates Inc reported $5.8B in U.S.-listed holdings across 98 positions for Q3 2025.
Its largest position, BNS, represents 4.4% of the portfolio.
Compared with Q2 2025, the fund opened 7 new positions and exited 2.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 92.2% · $5.4B
- ADR · 5.0% · $293M
- Other · 2.2% · $126M
- REIT · 0.6% · $33M
- ETP · 0.1% · $4M
Quarter-over-Quarter Changes full breakdown →
vs Q2 2025 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| CHVCHEVRON CORP NEW | NEW | +133.4K | 133.4K | +$21M | $21M |
| NVDANVIDIA CORPORATION | NEW | +6.3K | 6.3K | +$1M | $1M |
| PVLAPALVELLA THERAPEUTICS INC NE | NEW | +5.2K | 5.2K | +$325,988 | $325,988 |
| GOOGLALPHABET INC | NEW | +1.1K | 1.1K | +$265,465 | $265,465 |
| ALBALBEMARLE CORP | NEW | +2.5K | 2.5K | +$200,673 | $200,673 |
| GOSSGOSSAMER BIO INC | NEW | +39.4K | 39.4K | +$103,622 | $103,622 |
| PROKPROKIDNEY CORP | NEW | +15.9K | 15.9K | +$38,478 | $38,478 |
| UPSUNITED PARCEL SERVICE INC | ADDED | +333.9K | 340.1K | +$28M | $28M |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q3 2025
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $6.2B | 101 | May 12, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $6.1B | 100 | Feb 11, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $5.8B | 98 | Nov 12, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $5.2B | 93 | Aug 8, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $4.7B | 89 | May 8, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $5.2B | 100 | Feb 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $5.5B | 101 | Nov 7, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $5.3B | 104 | Aug 6, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $5.8B | 102 | May 8, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $5.5B | 96 | Feb 12, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $5.1B | 98 | Nov 9, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $5.4B | 94 | Aug 10, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | Under review | 89 | May 11, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | Under review | 97 | Feb 10, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $5.0B | 101 | Nov 10, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $5.7B | 100 | Aug 9, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $6.7B | 101 | May 11, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $7.0B | 107 | Feb 9, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $6.9B | 105 | Nov 3, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $7.5B | 106 | Jul 29, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $7.3B | 102 | May 11, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $7.3B | 106 | Feb 5, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $6.4B | 97 | Nov 9, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $6.8B | 100 | Aug 7, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $5.8B | 88 | May 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $10.0B | 92 | Feb 7, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $9.8B | 92 | Nov 5, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $9.9B | 93 | Aug 1, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $10.0B | 97 | May 10, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $9.0B | 113 | Feb 8, 2019 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.